Using PBPK Models to Assess Fetal Drug Exposure Blog Using PBPK Models to Assess Fetal Drug Exposure The tragedy of thalidomide provides a cautionary tale about the potential for birth defects resulting…CertaraJanuary 19, 2018
Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial Publication Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial CertaraJanuary 15, 2018
Best Practices for Developing High Quality, On Time Submissions White Paper Best Practices for Developing High Quality, On Time Submissions Sponsors often struggle with submission planning. Read this white paper to learn how to develop…CertaraJanuary 8, 2018
Model-informed Drug Development for Malaria Therapeutics Publication Model-informed Drug Development for Malaria Therapeutics CertaraJanuary 6, 2018
How to Perform Level C IVIVC in Phoenix On-Demand Webinar How to Perform Level C IVIVC in Phoenix Step-by-step guidance for Level C IVIVC studies.CertaraDecember 13, 2017
Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation Publication Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation CertaraNovember 30, 2017
D360 Partner Brochure D360 Partner D360 Partner is an affordable add-on product for D360 for external partners that allows for…CertaraNovember 8, 2017
Exposure-response of Veliparib to Inform Phase 2 Trial Design in Refractory or Relapsed Patients with Hematological Malignancies Publication Exposure-response of Veliparib to Inform Phase 2 Trial Design in Refractory or Relapsed Patients with Hematological Malignancies CertaraNovember 1, 2017
A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies Publication A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies CertaraOctober 30, 2017
Influence of Molecular Size on the Clearance of Antibody Fragments Publication Influence of Molecular Size on the Clearance of Antibody Fragments CertaraOctober 1, 2017